RUNX3 and neoplasm: RUNX3 was previously regarded as a tumor-suppressor gene for its inactivation promotes the progression of gastric cancer, lung cancer, colorectal cancer, and bladder cancer by upregulating oncogenes, such as YBX1 and GLI1, or abrogating ARF–P53 pathway (12–16).